Jennifer Champoux
Chief Operating Officer at MONTE ROSA THERAPEUTICS, INC.
Net worth: 809 999 $ as of 30/05/2024
Jennifer Champoux active positions
| Companies | Position | Start | End |
|---|---|---|---|
| MONTE ROSA THERAPEUTICS, INC. | Chief Operating Officer | 28/02/2021 | - |
| Human Resources Officer | 28/02/2021 | 27/05/2024 |
Career history of Jennifer Champoux
Former positions of Jennifer Champoux
| Companies | Position | Start | End |
|---|---|---|---|
H3 Biomedicine, Inc.
 H3 Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., H3 Biomedicine, Inc. is a precision oncology research and development subsidiary based in Cambridge, MA. The company is uniquely positioned to integrate real-world clinical evidence with the latest advances in cancer genomics. H3 is developing a pipeline of highly targeted, breakthrough medicines that have the potential to impact the future of cancer care and treatment. The CEO of the company is Takashi Owa. | Corporate Officer/Principal | - | - |
Training of Jennifer Champoux
| Indiana University | Graduate Degree |
Statistics
International
| United States | 4 |
Operational
| Chief Operating Officer | 1 |
| Human Resources Officer | 1 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| MONTE ROSA THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
H3 Biomedicine, Inc.
H3 Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., H3 Biomedicine, Inc. is a precision oncology research and development subsidiary based in Cambridge, MA. The company is uniquely positioned to integrate real-world clinical evidence with the latest advances in cancer genomics. H3 is developing a pipeline of highly targeted, breakthrough medicines that have the potential to impact the future of cancer care and treatment. The CEO of the company is Takashi Owa. | Health Technology |
- Stock Market
- Insiders
- Jennifer Champoux
- Experience